Life ScienceCompany
Bristol-Myers Squibb - Global Diabetes Business Ownership
Who owns Bristol-Myers Squibb - Global Diabetes Business?
Bristol-Myers Squibb - Global Diabetes Business is owned by AstraZeneca. It was acquired on February 3, 2014.
Bristol-Myers Squibb - Global Diabetes Business Business Overview
Where is Bristol-Myers Squibb - Global Diabetes Business headquartered?
Bristol-Myers Squibb - Global Diabetes Business is headquartered in United States.
What sector is Bristol-Myers Squibb - Global Diabetes Business in?
Bristol-Myers Squibb - Global Diabetes Business is a life science company.
Life Science M&A Summary in 2014
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.
Join Mergr to view all 237 acquisitions of life science companies in 2014, including 22 acquisitions by private equity firms, and 215 by strategics.